2021³âµµ Á¦ 107Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ ÃÖ¿ì¼ö±¸¿¬»ó ¼ö»óÀÚ·Î ¼±Á¤µÇ½ÉÀ» Áø½ÉÀ¸·Î ÃàÇϵ帳´Ï´Ù.
- ¸ðüžÆÀÇÇÐ
-
- ¼ö»óÀÚ : ÃÖÀº»ù(¼¿ïÀÇ´ë)
- ¼ö»ó³í¹® : ÀΰøÁö´ÉÀ» ÀÌ¿ëÇÑ Àӽżº ´ç´¢ Á¶±â ¿¹Ãø ¸ðµ¨ÀÇ °³¹ß
- ºÎÀÎÁ¾¾çÇÐ
-
- ¼ö»óÀÚ : ÀÌÁö¹Î(¾ÆÁÖÀÇ´ë)
- ¼ö»ó³í¹® : Secondary cytoreductive surgery for recurrent ovarian cancer: Who will benefit from the surgery?
- »ý½Ä³»ºÐºñÇÐ
-
- ¼ö»óÀÚ : Â÷ÀºÈ¯(ÀÎÁ¦ÀÇ´ë)
- ¼ö»ó³í¹® : Effects of Prenatal and Early Postnatal DEHP Exposure on Reproductive tract in CD-1 female mice
- ÀϹݺÎÀΰúÇÐ
-
- ¼ö»óÀÚ : ÃÖ¼º¿í(¿ï»êÀÇ´ë)
- ¼ö»ó³í¹® : Decreased expression of Ki-67 and type I collagen in uterine fibroids :
in vivo efffects of Gonadotropin-releasing hormone agonist or Ulipristal acetate